日本ベクトン・ディッキンソン 品質管理・研究開発・注射剤の製剤研究・CMO Official site

BD FACSymphony(TM) A3 Flow Cytometer

A customizable flow cytometer that provides hyperparameter analysis with a smaller installation footprint.

The BD FACSymphony(TM) A3 flow cytometer is one of the BD FACSymphony(TM) family, equipped with ultra-quiet VPX electronics and high-output laser high-sensitivity photomultiplier tubes (PMTs). - It can simultaneously detect up to 30 parameters and 28 colors. - It can be freely customized and designed according to experimental needs. - With BD's extensive product lineup, including BD Horizon Brilliant(TM) dyes, experiments can be designed flexibly. - It can be adapted flexibly to meet needs and budget.

Related Link - https://www.bdbiosciences.com/ja-jp/products/instr…

basic information

For more details, please contact us.

Price range

Delivery Time

Applications/Examples of results

For more details, please contact us.

BD FACSymphony(TM) A3 Flow Cytometer Catalog

PRODUCT

Recommended products

Distributors

BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.